WVE Earnings & Financial Statements
Wave Life Sciences Ltd.
$3.09
-$0.05(-1.59%)
36
Overall
60
Value
9
Tech
39
Quality
Market Cap
$608.88M
Volume
2.82M
52W Range
$3.37 - $21.73
Target Price
$19.00
WVE earnings and financial statements: Wave Life Sciences Ltd.'s income statement, balance sheet and cash flow statement, annual and quarterly.
WVE Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $42.73M | $108.30M | $113.31M | $3.65M | $40.96M |
| Operating income | -$215.38M | -$110.40M | -$68.00M | -$162.72M | -$127.02M |
| EBITDA | -$200.94M | -$93.11M | -$53.19M | -$151.03M | -$117.18M |
| Net income | -$204.38M | -$97.01M | -$57.51M | -$161.82M | -$122.25M |
| EPS (diluted) | $-1.21 | $-0.70 | $-0.54 | $-2.05 | $-2.36 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $638.50M | $352.21M | $274.95M | $146.39M | $207.01M |
| Total liabilities | $112.27M | $134.82M | $227.44M | $183.60M | $166.63M |
| Shareholders’ equity | $518.36M | $209.51M | $39.63M | -$45.09M | $32.50M |
| Cash and equivalents | $602.10M | $302.08M | $200.35M | $88.50M | $150.56M |
| Long-term debt | $9.40M | $17.77M | $25.40M | $32.12M | $24.95M |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | -$187.49M | -$151.03M | -$19.43M | -$127.78M | -$88.99M |
| Capital expenditure | -$718.0K | -$938.0K | -$1.11M | -$1.36M | -$560.0K |
| Free cash flow | -$188.21M | -$151.96M | -$20.55M | -$129.14M | -$89.55M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | WVE | $3.09 | -1.6% | 2.82M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |